Cetera Advisor Networks’s Sophiris Bio, Inc. SPHS Stock Holding History

Cetera Advisor Networks’s Portfolio SPHS Stock Details SPHS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-15,000	Closed	-$32K	–	1030
2017 Q3	$32K	Hold	15,000	–	–	﹤0.01%	910
2017 Q2	$33K	Hold	15,000	–	–	﹤0.01%	912
2017 Q1	$42K	Hold	15,000	–	–	﹤0.01%	908
2016 Q4	$42K	Hold	15,000	–	–	﹤0.01%	855
2016 Q3	$46K	Buy	+15,000	New	+$56.4K	﹤0.01%	1021

Other funds holding SPHS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BAM

Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Cetera Advisor Networks's SPHS Position: Q4 2017 in Review

Cetera Advisor Networks sold out of Sophiris Bio, Inc. (SPHS) in Q4 2017, closing a stake of 15,000 shares — an estimated $32K sold.

Cetera Advisor Networks first reported a position in SPHS in Q3 2016 and held it in 5 quarters. The position peaked at $46K in Q3 2016. 32 funds tracked by Wall St. Rank hold SPHS as of Q4 2017.

Cetera Advisor Networks reported no remaining Sophiris Bio, Inc. position as of Q4 2017 after selling out during the quarter.
Cetera Advisor Networks sold 15,000 Sophiris Bio, Inc. shares in Q4 2017, an estimated $32K.
Cetera Advisor Networks first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 5 quarters.
Cetera Advisor Networks's Sophiris Bio, Inc. position peaked at $46K in Q3 2016.
32 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q4 2017.

Based on Cetera Advisor Networks's 13F filing for Q4 2017, filed 8 Feb 2018.